← Snapshot 21

Orange Book snapshot 21: Products

Products page 313 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
15602A080481001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHC (HYDROCORTISONE)C AND M PHARMA0.5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNC AND M PHARMACAL INC201877b555647c79acfcef35e6cc911ad8f0cfb37ad4f82b02fe7ae3293af816
15603A080481002HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHC (HYDROCORTISONE)C AND M PHARMA1%[]Approved Prior to Jan 1, 1982YesNoNoDISCNC AND M PHARMACAL INC79f52bc2061337581b68fe338e380ab90666ec6ec2f6fdde3f166753a9fe2e9a
15604A087796001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEACTAVIS MID ATLANTIC1%[]1982-10-13Oct 13, 1982NoNoNoDISCNACTAVIS MID ATLANTIC LLCce78a881ab48c45c6459389045e06bae04f5208c115eee9e81f9f38d52830adf
15605A080489002HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEALTANA0.5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNALTANA INC0253b78d96c014255471b9db514ffc3764a08e3df4822d3fa465be2364c007da
15606A080489003HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEALTANA1%[]Approved Prior to Jan 1, 1982YesNoNoDISCNALTANA INC80c86e24c19dff3d1c8335873d687f36d303dad8343a2aed2c187f11d1f11a5c
15607A086079001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEAMBIX1%[]Approved Prior to Jan 1, 1982YesNoNoDISCNAMBIX LABORATORIES DIV ORGANICS CORP AMERICA8564cb7ee21d9351e2ef9deb30eba433095ffcb760bcb5a7645d53d6c3a982fb
15608A086272001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEAMBIX2.5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNAMBIX LABORATORIES DIV ORGANICS CORP AMERICAfc0fb5666d4209b940f1d411deba45f0a734a8597c4565f1be4de0f7936a4ff3
15609A080692001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEFOUGERA PHARMS1%AT["AT"]Approved Prior to Jan 1, 1982YesNoYesRXFOUGERA PHARMACEUTICALS INC9e5d7b307c5ea448f57db5d4a6a49613e119ca5722d503a50833bcd87e1682ef
15610A081203001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEFOUGERA PHARMS INC2.5%AT["AT"]1993-05-28May 28, 1993NoNoYesRXFOUGERA PHARMACEUTICALS INC80e164318e4097570694a7b07a28268b7852984a559a988bc2286f8c6b897815
15611A089704001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONENASKA1%[]1988-03-10Mar 10, 1988NoNoNoDISCNNASKA PHARMACAL CO INC DIV RUGBY DARBY GROUP COSMETICS800bfe1c17a534d000377626bcf4b5bd820a37f699dd504c3e8c184f9943a0a8
15612A084969003HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEPERRIGO NEW YORK0.5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNPERRIGO NEW YORK INCa9b28f06e6097fbd46c80a5d0e0ea5c5e7dc793deb4a5598730e3fdfeaa7dffb
15613A085028001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEPERRIGO NEW YORK1%[]Approved Prior to Jan 1, 1982YesNoNoDISCNPERRIGO NEW YORK INC468d637fcebcfaabfa97306c9d81b0284df21388020f2e30be9febc1a778d97b
15614A085027001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEPERRIGO NEW YORK2.5%AT["AT"]Approved Prior to Jan 1, 1982YesNoNoRXPERRIGO NEW YORK INCc77719f23a125c0ba3001e15c5573adfc2d5a5c1bff6adbc6cef1ad86d56f91e
15615A088842001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEPHARMADERM1%[]1987-02-09Feb 9, 1987NoNoNoDISCNPHARMADERM DIV ALTANA INCf53f5b8f5bc3d71a41245c25e6f11527bd548734a1041cbb69185ba1ff5af478
15616A086256001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONETARO0.5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNTARO PHARMACEUTICALS USA INCd00649baa08b33b628fadadde0af68c7e859c906f9624af0f988511c782c24ef
15617A086257001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONETARO1%AT["AT"]Approved Prior to Jan 1, 1982YesNoNoRXTARO PHARMACEUTICALS USA INCbbc57573319fe70f640f5d4b13b93bf8b89d0bfde04af4c6e9e9785ef83339c4
15618A040310001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONETARO2.5%[]2000-12-29Dec 29, 2000NoNoNoDISCNTARO PHARMACEUTICALS USA INC1a8f857a6dcaf7fa97abf1499bc7d1de10c348a8242da8fe163f160bbd664404
15619A088061001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEUSL PHARMA1%[]1983-09-27Sep 27, 1983NoNoNoDISCNUSL PHARMA INC164598f338d51c1428553f403007d9c875f15ff0f00291f5205b65e00fa0279e
15620A088039001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONEUSL PHARMA2.5%[]1983-09-27Sep 27, 1983NoNoNoDISCNUSL PHARMA INC1d535808cec6b192d3abd2c0d31eedaa95269bde4c690aa200cad9c976a6bdcc
15621A076842001HYDROCORTISONE BUTYRATEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONE BUTYRATETARO0.1%AB["AB"]2004-12-27Dec 27, 2004NoNoNoRXTARO PHARMACEUTICAL INDUSTRIES LTD5f52f7ef15c214d50e581723ec6ddbdd179bf3362ff9f2033146f8b81c4b7d5c
15622A088138001HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONE IN ABSORBASECMP PHARMA INC1%AT["AT"]1985-09-06Sep 6, 1985NoNoNoRXCMP PHARMA INC1ec4fedac4b7d60efd54c441f8d66630d22678775fb5ffe0622131aba7a0f1b7
15623A211764001HYDROCORTISONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONE VALERATECOSETTE0.2%AB["AB"]2020-03-04Mar 4, 2020NoNoNoRXCOSETTE PHARMACEUTICALS INCd7eb44b02457c322dbf278f9aa80a0a4839560935700d3f921cd6d50428d48e4
15624A075085001HYDROCORTISONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONE VALERATEFOUGERA PHARMS0.2%[]2001-07-31Jul 31, 2001NoNoNoDISCNFOUGERA PHARMACEUTICALS INC756cb071de56f34431b4628d056b6bdd5ed63d46db244c3519026dbbdd8567d5
15625A211750001HYDROCORTISONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONE VALERATEGLENMARK PHARMS LTD0.2%AB["AB"]2018-12-14Dec 14, 2018NoNoNoRXGLENMARK PHARMACEUTICALS LTD8015968ba441e8ed37cc5151933e7e942fd496507b883e907c50741e3c0b5faf
15626A075043001HYDROCORTISONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALHYDROCORTISONE VALERATETARO0.2%AB["AB"]1998-08-25Aug 25, 1998NoNoYesRXTARO PHARMACEUTICALS USA INCe00d6885cca989d517a95e8e25670499c993163ac72794a9ce964c467b170788
15627A080474003HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYTONEDERMIK LABS1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesNoNoDISCNDERMIK LABORATORIES DIV AVENTIS PHARMACEUTICALS INC0f7440829eb3253c52acbd406fcf29995457c11b659a27b3ac9781eebd11e0dd
15628A080474004HYDROCORTISONEOINTMENT;TOPICALOINTMENTTOPICALHYTONEDERMIK LABS2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesNoNoDISCNDERMIK LABORATORIES DIV AVENTIS PHARMACEUTICALS INC152e0320c132bc87de13be6ce9b3063c2cfa6bed44726503aef32bc407203df1
15629A083944001TRIAMCINOLONE ACETONIDEOINTMENT;TOPICALOINTMENTTOPICALKENALOGDELCOR ASSET CORP0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesNoNoDISCNDELCOR ASSET CORP7b9aa1e5aafc4debbd996f7bf95df432d64038f59303d1d59da34ac782d03d7a
15630N213189001TIRBANIBULINOINTMENT;TOPICALOINTMENTTOPICALKLISYRIALMIRALL1%[]2020-12-14Dec 14, 2020NoYesYesRXALMIRALL LLC1f0a9f1cc4bd78ed77d11279f47c6aa9819d8398a36b367b2f49ad69f613f941
15631A062499001BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATEOINTMENT;TOPICALOINTMENTTOPICALLANABIOTICCOMBE400 UNITS/GM;40MG/GM;EQ 5MG BASE/GM;5,000 UNITS/GM[]1985-06-03Jun 3, 1985NoNoNoDISCNCOMBE INC1a508c9f28f9b3e3def1f29fde33f6caa17a3e15a2aae403326c1cc889809694
15632N016909002FLUOCINONIDEOINTMENT;TOPICALOINTMENTTOPICALLIDEXCNTY LINE PHARMS0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**AB["AB"]Approved Prior to Jan 1, 1982YesYesNoRXCOUNTY LINE PHARMACEUTICALS LLCaa5c0d01328d00b1ac7213ea118b45b3aa25a0555ac7d3cafd50b79b6ce411b7
15633A211469001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEALEOR DERMACEUTICALS5%AT["AT"]2018-11-23Nov 23, 2018NoNoNoRXALEOR DERMACEUTICALS LTD41a9fd94b4f2c85abd9ed6bc29e740614a1cd34e73faedd5c9b4b3bb47d081aa
15634A207810001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEALKEM LABS LTD5%AT["AT"]2017-03-10Mar 10, 2017NoNoNoRXALKEM LABORATORIES LTDa0b6df0bfee8ebecbbac3744f34d9c29902176d5e83ca9d0b16cead9db4f4d7a
15635A206297001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEAMNEAL PHARMS5%AT["AT"]2015-08-07Aug 7, 2015NoNoNoRXAMNEAL PHARMACEUTICALS9bfe34e7d4906c0ddfcd4aa52aae869f1e88a5bcce201e5a2f33210e38bd25bd
15636A080210001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEBELMORA LLC5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNBELMORA LLC86857e74c2099344fa8022728560054aabfba4ce1f77309c164dd5b27a806bcb
15637A211019001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINECOSETTE5%AT["AT"]2018-12-12Dec 12, 2018NoNoNoRXCOSETTE PHARMACEUTICALS INC167f9a702ba62a23aa4dbb1203ba5b82c845b27e5180d5cfab19fcf56e428c4f
15638A208660001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEDR REDDYS5%AT["AT"]2021-01-05Jan 5, 2021NoNoNoRXDR REDDYS LABORATORIES LTD9b26d3538250ccd8a3c2a0f692a51e6bb284b900f9d4888d58f12a45f8ba6447
15639A080198001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEFOUGERA PHARMS INC5%AT["AT"]Approved Prior to Jan 1, 1982YesNoYesRXFOUGERA PHARMACEUTICALS INC6c9c83e91aa6dfba458fc9c2951feb54a54222e0ebafcb0a44a640ae9c1d339e
15640A212486001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEGENEYORK PHARMS5%[]2019-10-17Oct 17, 2019NoNoNoDISCNGENEYORK PHARMACEUTICALS GROUP LLCce22c4a711bb89a8f780b4915f0c86b14ab382716500e9cc81cd63cfdaec48be
15641A206498001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEGLENMARK PHARMS LTD5%AT["AT"]2016-09-09Sep 9, 2016NoNoNoRXGLENMARK PHARMACEUTICALS LTD6ba0a6aab66266eb402f7965d7bedff3e0f3f2eb23e4d6139d19707f8bde66ee
15642A211697001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEMACLEODS PHARMS LTD5%AT["AT"]2020-03-16Mar 16, 2020NoNoNoRXMACLEODS PHARMACEUTICALS LTDe2499041f902ecb96af0c17182e3d7e9814f91f7ca6cab489b807abd363a24ce
15643A208604001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINENOVAST LABS5%[]2017-09-20Sep 20, 2017NoNoNoDISCNNOVAST LABORATORIES LTDf3c5db4857e415fca1dcb1f84933d5a5b029ed5de858e28e7d657d1c32f8efa0
15644A040911001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINESEPTODONT INC5%AT["AT"]2011-05-23May 23, 2011NoNoNoRXSEPTODONT INCdcae0e3cda27645efcc7a797855d73ca8e132cb308deb8c884ef5db0570011c8
15645A210958001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINESTRIDES PHARMA5%AT["AT"]2018-12-11Dec 11, 2018NoNoNoRXSTRIDES PHARMA GLOBAL PTE LTD97707aac17eae38060fd4c7615f50282c088b96168747528326a31fc6d98a079
15646A086724001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINETARO5%AT["AT"]Approved Prior to Jan 1, 1982YesNoNoRXTARO PHARMACEUTICALS USA INC71561bf3bd583989222a25c2312b992509c22d9eda8df7b212fac9281d663660
15647A205318001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINETELIGENT5%AT["AT"]2016-02-01Feb 1, 2016NoNoNoRXTELIGENT PHARMA INC644fab37e556dd61cb720451c892beb9a9aaab16c76eba5d9ff8132d4b40c322
15648A210256001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINETEVA PHARMS USA5%[]2018-01-16Jan 16, 2018NoNoNoDISCNTEVA PHARMACEUTICALS USA INCac45d1eba7be15e7030f725f28ff40cf0589e5dcebf89b602ce1f5b4e22093a5
15649A208822001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALLIDOCAINEVITRUVIAS THERAP5%AT["AT"]2017-09-25Sep 25, 2017NoNoNoRXVITRUVIAS THERAPEUTICS LLC0ea90169a4a09453b7652a683947c5402c73bdbad492cef589944600b90d986a
15650N018652001HYDROCORTISONE BUTYRATEOINTMENT;TOPICALOINTMENTTOPICALLOCOIDPRECISION DERMAT0.1%AB["AB"]1982-10-29Oct 29, 1982NoYesYesRXPRECISION DERMATOLOGY INCf1c0df75416c7ef0c483a6ff9419c3bbc2d3d7443a30f9610eee0ba7a669fab0
15651N019106001HYDROCORTISONE BUTYRATEOINTMENT;TOPICALOINTMENTTOPICALLOCOIDYAMANOUCHI0.1%[]1984-07-03Jul 3, 1984NoNoNoDISCNYAMANOUCHI EUROPE BVb35e8921e44d7ace5750de81a7e22488de748d6ae71fb848518256d657dcad14